This analysis identified 522 genes whose expression during CD4+ T cell activation has potential effects on pan‐cancer risk using a strong instrument approach and identified 23 additional effects that were validated using five or more weak instrument methods (Table S4F, Supporting Information). Here, CD4 is linked to cancer.